Functions of IκB proteins in inflammatory responses to Escherichia coli LPS in mouse lungs

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 5, 2002, Pages 575-582

  Mizgerd, Joseph P ^a   Scott, Martin L ^a   Spieker, Matt R ^a   Doerschuk, Claire M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; MURINAE;

GUANOSINE 3',5' POLYPHOSPHATE SYNTHETASES; GUANOSINE 3',5'-POLYPHOSPHATE SYNTHETASES; I KAPPA B; I KAPPA B BETA; LIGASE; LIPOPOLYSACCHARIDE; NFKBIE PROTEIN, MOUSE; ONCOPROTEIN;

ANIMAL; ARTICLE; BACTERIAL PNEUMONIA; CELL NUCLEUS; EDEMA; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENETICS; LUNG; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; NEUTROPHIL; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; CELL NUCLEUS; EDEMA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; I-KAPPA B PROTEINS; LIGASES; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, MUTANT STRAINS; NEUTROPHILS; PHOSPHORYLATION; PNEUMONIA, BACTERIAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS;

EID: 0036826910     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0015OC     Document Type: Article

References (40)

1. Michaud, C. M., C. J. L. Murray, and B. R. Bloom. 2001. Burden of disease: Implications for future research. JAMA 285:535-539.
2. Richards, M. J., J. R. Edwards, D. H. Culver, and R. P. Gaynes. 1999. Nosocomial infections in medical intensive care units in the United States: National nosocomial infections surveillance system. Crit. Care Med. 27:887-892.
3. Ruiz, M., S. Ewig, A. Torres, F. Arancibia, F. Marco, J. Mensa, M. Sanchez, and J. A. Martinez. 1999. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am. J. Respir. Crit. Care Med. 160:923-929.
4. Martin, T. R. 2000. Recognition of bacterial endotoxin in the lungs. Am. J. Respir. Cell Mol. Biol. 23:128-132.
5. Frevert, C. W., S. Huang, H. Danaee, J. D. Paulauskis, and L. Kobzik. 1995. Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J. Immunol. 154:335-344.
6. Schmal, H., T. P. Shanley, M. L. Jones, H. P. Friedl, and P. A. Ward, 1996. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156:1963-1972.
7. Greenberger, M J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
8. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157:5016-5021.
9. Kumasaka, T., W. M. Quinlan, N. A. Doyle, T. P. Condon, J. Sligh, F. Takei, A. L. Beaudet, C. F. Bennett, and C. M. Doerschuk. 1996. The role of ICAM-1 in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides. anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97:2362-2369.
10. Mizgerd, J. P., M. R. Spieker, and C. M. Doerschuk. 2001. Early response cytokines and innate immunity: Essential roles for TNFR1 and ILIR1 during Escherichia coli pneumonia in mice. J. Immunol. 166:4042-4048.
11. Pahl, H. L. 1999. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866.
12. Blackwell, T. S., L. H. Lancaster, T. R. Blackwell, A. Venkatakrishnan, and J. W. Christman. 1999. Differential NF-κB activation after intratracheal endotoxin. Am. J. Physiol. 277:L823-830.
13. Mizgerd, J. P., J. J. Peschon, and C. M. Doerschuk. 2000. Roles of tumor necrosis factor signaling during murine Escherichia colipneumonia in mice. Am. J. Respir. Crit. Care Med. 22:85-91.
14. Alcamo, E. A., J. P. Mizgerd, B. H. Horwitz, R. Bronson, A. A. Beg, M. Scott, C. M. Doerschuk, R. O. Hynes, and D. Baltimore. 2001. Targeted mutation of tumor necrosis factor 1 rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immnol. 167:1592-1600.
15. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
16. Li, Z., and G. J. Nabel. 1997. A new member of the I kappa B protein family, I kappa B epsilon, inhibits RelA (p65)-mediated NF-kappa B transcription. Mol. Cell. Biol. 17:6184-6190.
17. Simeonidis, S., D. Stauber, G. Chen, W. A. Hendrickson, and D. Thanos. 1999. Mechanisms by which I kappa B proteins control NF-kappa B activity. Proc. Natl. Acad. Sci. USA 96:49-54.
18. Whiteside, S. T., J. C. Epinat, N. R. Rice, and A. Israel. 1997. I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J. 16:1413-1426.
19. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
20. Johnson, D. R., I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober. 1996. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271:16317-16322.
21. Velasco, M., M. J. Diaz-Guerra, P. Martin-Sanz, A. Alvarez, and L. Bosca. 1997. Rapid up-regulation of IκB-β and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 272:23025-23030.
22. Liu, L., Y. T. Kwak, F. Bex, L. F. Garciamartinez, X. H. Li, K. Meek, W. S. Lane, and R. B. Gaynor. 1998. DNA-dependent protein kinase phosphorylation of I kappa B-alpha and I kappa B-beta regulates NF-kappa-B DNA binding properties. Mol. Cell. Biol. 18:4221-4234.
23. Heilker, R., F. Freuler, R. Pulfer, F. Di Padova, and J. Eder. 1999. All three I kappa B isoforms and most Rel family members are stably associated with the I kappa B kinase 1/2 complex. Eur. J. Biochem. 259:253-261.
24. Heilker, R., F. Freuler, M. Vanek, R. Pulfer, T. Kobel, J. Peter, H. G. Zerwes, H. Hofstetter, and J. Eder. 1999. The kinetics of association and phosphorylation of I kappa B isoforms by I kappa B kinase 2 correlate with their cellular regulation in human endothelial cells. Biochemistry 38:6231-6238.
25. Peters, R. T., S. M. Liao, and T. Maniatis. 2000. IKK epsilon is part of a novel PMA-inducible I kappa B kinase complex. Mol. Cell 5:513-522.
26. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
27. Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor κB inhibitors IκB-α and IκB-β. J. Exp. Med. 188:1055-1062.
28. Johnson, C., D. Van Antwerp, and T. J. Hope. 1999. An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of I kappa B alpha. EMBO J. 18:6682-6693.
29. Tam, W. F., L. H. Lee, L. Davis, and R. Sen. 2000. Cytoplasmic sequestration of Rel proteins by I kappa B alpha requires CRM1-dependent nuclear export. Mol. Cell Biol. 20:2269-2284.
30. Huang, T. T., N. Kudo, M. Yoshida, and S. Miyamoto. 2000. A nuclear export signal in the N-terminal regulatory domain of I kappa B alpha controls cytoplasmic localization of inactive NF-kappa B/I kappa B alpha complexes. Proc. Nat. Acad. Sci. USA 97:1014-1019.
31. Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκB-β in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444-5449.
32. Phillips, R. J., and S. Ghosh. 1997. Regulation of I kappa B-beta in WEHI 231 mature B cells. Mol. Cell. Biol. 17:4390-4396.
33. Huang, T. T., and S. Miyamoto. 2001. Postrepression activation of NF-kappa B requires the amino-terminal nuclear export signal specific to I kappa B alpha. Mol. Cell. Biol. 21:4737-4747.
34. Shenkar, R., H. K. Yum, J. Arcaroli, J. Kupfner, and E. Abraham, 2001. Interactions between CBP, NF-kappaB, and CREB in the lungs after hemorrhage and endotoxemia. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L418-426.
35. Mizgerd, J. P., H. Kubo, G. J. Kutkoski, S. D. Bhagwan, K. Scharffetter-Kochanek, A. L. Beaudet, and C. M. Doerschuk. 1997. Neutrophil emigration in the skin, lungs, and peritoneum: Different requirements for CD11/CD18 revealed by CD18-deficient mice. J. Exp. Med. 186:1357-1364.
36. McDonald, P. P., C. Bovolenta, and M. A. Cassatella. 1998. Activation of distinct transcription factors in neutrophils by bacterial LPS, interferon-gamma, and GM-CSF and the necessity to overcome the action of endogenous proteases. Biochemistry 37:13165-13173.
37. Calkins, C. M., D. D. Bensard, J. K. Heimbach, X. Meng, B. D. Shames, E. J. Pulido, and R. C. McIntyre, Jr. 2001. L-arginine attenuates lipopolysaccharide-induced lung chemokine production. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L400-408.
38. Lentsch, A. B., B. J. Czermak, N. M. Bless, and P. A. Ward. 1998. NF-kappa B activation during IgG immune complex-induced lung injury: Requirements for TNF-alpha and IL-1 beta but not complement. Am. J. Pathol. 152:1327-1336.
39. Lentsch, A. B., J. A. Jordan, B. J. Czermak, K. M. Diehl, E. M. Younkin, V. Sarma, and P. A. Ward. 1999. Inhibition of NF-kappa B activation and augmentation of I kappa B-beta by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154:239-247.
40. Venkatakrishnan, A., A. A. Stecenko, G. King, T. R. Blackwell, K L. Brigham, J. W. Christman, and T. S. Blackwell. 2000. Exaggerated activation of nuclear factor-kappa B and I kappa B-beta processing in cystic fibrosis bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 23:396-403.